Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12614000807651
ACTRN12614000807651
Completed
Phase 4

The effect of a single dose of Citalopram compared to placebo on the circadian systems response to light in healthy adults.

Monash University0 sites20 target enrollmentJuly 30, 2014
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Monash University
Enrollment
20
Status
Completed
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 30, 2014
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Healthy Caucasian males and females

Exclusion Criteria

  • •\- Any history of psychiatric illness or use of psychiatric medication
  • •\- Current sleep disorders or erratic/unusual sleep patterns
  • •\- Recent or excessive illicit drug use
  • •\- Current use of any prescription medication
  • •\- Colourblindness
  • •\- Recent surgery involving a full anaesthetic
  • •\- Any night shift within the past 3 months
  • •\- Any travel outside of the current time zone within the last 3 months
  • •\- BMI less than 18 or greater than 30
  • •\- Epworth Sleepiness Scale score greater than 10

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 4
The effect of a selective serotonin reuptake inhibitor (SSRI) on the brain's response to lightDepressive disordersMental Health - Depression
ACTRN12618000885291Monash University24
Recruiting
Phase 2
A comparative study of the effect of citalopram in the prevention of delirium in intubated patients without brain damage in Labafinejad Hospital IC
IRCT20190215042716N6Shahid Beheshti University of Medical Sciences62
Recruiting
Phase 3
Effect of Citalopram on Endometriosis
IRCT20180211038692N2Tehran University of Medical Sciences80
Active, not recruiting
Phase 1
A trial to study effects of a single dose Citalopram on emotion processing in female patients with Borderline Personality Disorder and the associated modulation of fMRI BOLD signalsBorderline Personality DisorderMedDRA version: 20.0 Level: PT Classification code 10006034 Term: Borderline personality disorder System Organ Class: 10037175 - Psychiatric disordersTherapeutic area: Psychiatry and Psychology [F] - Mental Disorders [F03]
EUCTR2018-001212-30-DECentral Institute of Mental Health, represented by commercial and administrative Director30
Completed
Phase 4
The effect of citalopram versus a placebo on central auditory processing in the elderly.
ACTRN12614000570684Jose Fernando Polanski60